Recent Headlines
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors
F2G Limited, the UK based antifungal drug discovery and development company, today announced the appointment of Dr Michael R. Hodges to the Company’s Board of Directors. Michael R Hodges, M.D., BSc., MRCP (UK) has 20 years of biopharmaceutical development experience and has worked in both... - September 13, 2010 - F2G Ltd
Synpromics: Scotland’s Latest Biotech Company
Synpromics announces its incorporation as Scotland’s latest biotech company. The new company aims to focus its activities in the area of synthetic biology and has acquired its patents from its managing director; Dr Michael Roberts. - September 12, 2010 - Synpromics Ltd
AnaSpec Signs Distribution Agreement with Interprise Brasil
AnaSpec, Inc. and Interprise Brasil today announced a non-exclusive distributor agreement that will allow Interprise Brasil to distribute AnaSpec’s catalog and custom products throughout Brasil. - August 28, 2010 - AnaSpec, EGT Group
Bio-Med QC Offers an Indiana Pharmacy Exclusive
Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC
AnaSpec Visits with Noted Alzheimer’s Researcher, Dr. Patrick McGeer
AnaSpec’s general manager, Dr. Anita Hong and technical support specialist, Cecilia Po, visited the highly published and eminent Alzheimer’s researcher, Dr. Patrick McGeer and his associate, Dr. Jian-Ping Guo at the University of British Columbia, Vancouver, Canada on Aug. 12, 2010. - August 22, 2010 - AnaSpec, EGT Group
The Porcine microRNAome is Revealed
Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC
AnaSpec Introduces SensoLyte® Biotin Quantitation Assay Kit
AnaSpec is pleased to announce the release of the FRET based biotin quantitation kit. The SensoLyte® Biotin Quantitation Assay Kit provides a convenient way to estimate the efficiency of biotinylation for biotin-protein conjugates. The kit also can be used in quantitate biotin concentration in a solution. - August 20, 2010 - AnaSpec, EGT Group
CHI’s BioPharma Strategy Series Presents the Inaugural Mitigating Safety Risks in Early Clinical Development Executive Forum November 8-9, 2010, Philadelphia, PA
Presentations Discuss Bridging the Gap Between Pre-Clinical and Clinical Safety to Improve Prediction. - August 20, 2010 - Cambridge Healthtech Institute
AnaSpec Introduces Speedy 28-Day Antibody Service
AnaSpec introduces the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds. The first bleed, obtained at the accelerated rate of Day 21 after... - August 11, 2010 - AnaSpec, EGT Group
Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform
CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions
AnaSpec’s Published References Pass 1000
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 1000. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - July 21, 2010 - AnaSpec, EGT Group
Wockhardt Foundation Achieves Another Milestone - Over 200 Cleft Surgeries in Association with Smile Train
Wockhardt Foundation, in collaboration with Smile train has successfully completed over 200 surgeries. - July 18, 2010 - Wockhardt Foundation
200,000 Patients Screened by Wockhardt Foundation Within 200 Days
Wockhardt Foundation screens over 200,000 patients. - July 18, 2010 - Wockhardt Foundation
InnoCore and Nanomi Strengthen Collaboration in Microsphere Technology for Peptide and Protein Delivery
InnoCore Technologies BV and Nanomi BV announce a strategic collaboration for the development of advanced monodisperse biodegradable microsphere-based controlled release formulations for the sustained delivery of biotherapeutics. - July 14, 2010 - Nanomi
The NIH Awards Aciont® a Small Business Catalyst Award Grant Accelerating Innovative Research
Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®.” - July 08, 2010 - Aciont Inc.
Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance with Lactagen
Customer Experience Reports indicate relief from the symptoms of lactose intolerance using the Lactagen® program of colonic adaptation. - July 02, 2010 - Lactagen
Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010 - Stemedica Cell Techechnologies
Wockhardt Foundation Awarded ‘Pharma CSR Organization of the Year 2010’
Wockhardt Foundation wins the CSR award under the leadership of Huzaifa Khorakiwala who through his Human Values has created a team of dedicated warriors to work towards the upliftment of the poor weak and needy. - July 02, 2010 - Wockhardt Foundation
The 5th BIO KOREA 2010, Korea’s Largest Exhibition & Conference, on Biotech in Seoul, 1-3 September
The 5th BIO KOREA 2010 Conference & Exhibition will be held from September 1 to 3, 2010 at COEX in Seoul/Korea. BIO KOREA of this year offers a variety of high-level conference, international exhibition and partnership events and provides an opportunity to find business and technology partners. It expects to 265 companies and about 19,000 visitors from across the globe. - June 29, 2010 - Bio Korea
Functional Genetics Announces Two Separate Awards from the National Institute of Allergy and Infectious Diseases to Develop Broad Spectrum Antivirals
Functional Genetics, Inc. today announced the awarding of two different Phase II SBIR awards from the National Institute of Allergy and Infectious Diseases (NIAID) to pursue innovative approaches for antibody-based targeting of infectious diseases. Under the terms of the agreement, Functional... - June 29, 2010 - Functional Genetics, Inc.
AnaSpec Introduces New SensoLyte® uPA & tPA Assay Kits
AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. - June 19, 2010 - AnaSpec, EGT Group
Advanced Cell Technology Awarded Broad Patent for Production of Retinal Pigment Epithelial Cells
This broad patent gives Advanced Cell Technology the opportunity to have a monopoly around embryonic stem cells derived from RPE cells. There are over 200 diseases and conditions which potentially be treated with RPE-derived cells. - June 18, 2010 - Advanced Cell Technology, Inc.
AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica
AnaSpec, Inc. and Bioeasy Diagnostica today announced a non-exclusive distributor agreement that will allow Bioeasy Diagnostica to distribute AnaSpec’s catalog and custom products throughout Brasil. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec... - June 18, 2010 - AnaSpec, EGT Group
BIOCIUS Life Sciences and BlueSky Biotech Extend Partnership, Provide Validated Enzymes Fully‐Validated SIRT1 Enhances Drug Discovery Investigation
BIOCIUS Life Sciences Inc., developers of the RapidFire® highthroughputmass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry’s only Sirtuin (SIRT, silent mating type information regulation... - June 18, 2010 - Blue Sky Biotech
Wockhardt Foundation Celebrates Service Commitment Day on 5th & 7th June with Zest, Energy & Activities
Dedicated warriors of Wockhardt Foundation across all sites, celebrated Service Commitment Day on 5th & 7th of June, in a unique fashion. US operations in both Morton Grove Pharmaceuticals and Wockhardt USA New Jersey conducted a food drive for local food banks that serve the poor, weak &... - June 13, 2010 - Wockhardt Foundation
AsymmetRx Medical Signs Multi Year Agreement with Ventana Medical a Member of the Roche Group
AsymmetRx Medical, Inc. an Acton, MA based Biotechnology Company, announced the signing of a license agreement with Ventana Medical, A member of the Roche Group. This agreement provides Ventana with the exclusive license and distribution rights of their patented Prostate Cancer Diagnostic tool... - June 11, 2010 - AsymmetRx Medical, Inc.
Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies in June 14 DIA Session
Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency - June 10, 2010 - Health Decisions
AnaSpec Introduces Rhodamine 110 Labeled GO® Peptides
Rhodamine 110 (Rh110)-labeled peptides are used in the study of a number of protease activity. - June 05, 2010 - AnaSpec, EGT Group
The Allogeneic Adult Stem Cells Company Announcing Appointment of Dr. Lev Verkh
Lev Verkh is now a part of Stemedica, the allogeneic adult stem cells manufacturing company for effective stem cell clinical trials, thus improving the life of humans. - June 05, 2010 - Stemedica Cell Techechnologies
Health Decisions Encourages DIA Attendees to Demand More Than the Industry’s 10% Rate of On-Time Enrollment in Clinical Trials (Booth 929)
CRO demonstrates techniques that reverse the tide of enrollment delays in clinical research. - May 29, 2010 - Health Decisions
AnaSpec Introduces New SensoLyte® GSH and GST Assay Kits
AnaSpec has introduced two new Glutathione (GSH) related kits - the SensoLyte® Glutathione Cellular Assay Kit and the SensoLyte® GST Activity Assay Kit to complement the colorimetric and fluorimetric SensoLyte® Total GSH assay kits. The SensoLyte® Glutathione Cellular Assay Kit... - May 28, 2010 - AnaSpec, EGT Group
1,50,000 Patients in the First 5 Months: Another Milestone by Wockhardt Foundation
Wockhardt Foundation completed 1,50,000 medical check ups through its 2 Mobile Medical Unit programmes in the first 5 months of 2010. - May 28, 2010 - Wockhardt Foundation
AnaSpec Introduces Anti-5-Methylcytidine Monoclonal Antibody
AnaSpec has introduced the popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. - May 23, 2010 - AnaSpec, EGT Group
Ritter Pharmaceuticals Launches Redesigned Website for Lactagen
Ritter Pharmaceuticals, Inc. announces the launch of a newly redesigned website for their lactose intolerance product, Lactagen (www.lactagen.com). - May 23, 2010 - Lactagen
Prof. Muhammad Yunus Captures the Mind of Vienna in the First Leg of the Social Business Tour 2010
The Social Business Tour 2010 commenced with grand style and purpose in Vienna on May 11th. This tour involved the process of spreading awareness of the concept named "Social Business." - May 21, 2010 - Wockhardt Foundation
VIRUN® to Premiere OmegaH2O® Through WEDAR at CPhI and HI/NI in Shanghai, China
Virun to premiere water soluble and shelf stable OmegaH2O® in China through WEDAR Biotechnology Co. Ltd. OmegaH2O® is patents pending. - May 18, 2010 - VIRUN
Luke Roush Named Vice President of Global Marketing at TransEnterix
Roush is responsible for setting and executing TransEnterix’s worldwide marketing and commercialization strategy, which includes communicating the benefits of the company’s SPIDER® Surgical System to hospitals, surgeons and patients. - May 14, 2010 - TransEnterix
Acclaimed Film-Maker Shekar Kapur Joins the Advisory Board of Wockhardt Foundation
Shekhar Kapur joins advisory board of the prestigious Wockhardt Foundation. - May 14, 2010 - Wockhardt Foundation
AnaSpec Introduces ClearPoint™ β-Amyloid Custom Peptides
AnaSpec, the world’s largest provider of β-amyloid peptide and Alzheimer’s research reagents , has introduced its ClearPoint™ β-Amyloid custom peptide synthesis service. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope... - May 12, 2010 - AnaSpec, EGT Group
Wockhardt Foundation and Sattad Welfare Association Join Hands for a Noble Cause
A mega medical camp was organized by Wockhardt Foundation in collaboration with Sattad Welfare organization at Badarbaug, Masjid Bunder on 2nd May 2010. A dedicated team which included Dr. Shailesh Nangare along with Dr. Sumit Patwari did a thorough medical examination of the poor, weak and needy... - May 09, 2010 - Wockhardt Foundation
RayBiotech Announces Biomarker Grant Awardees
RayBiotech, Inc., the Protein Array Pioneer Company, has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. - May 06, 2010 - RayBiotech, Inc
AnaSpec Introduces Novel Solid Support AMC Resin
AnaSpec has announced the development of a novel solid support AMC resin for facile solid-phase synthesis of peptide-AMCs. - May 06, 2010 - AnaSpec, EGT Group
Former Ms. India Universe Gul Panag Joins the Advisory Board of the Prestigious Wockhardt Foundation
Gul Panag who has set a perfect example for beauty with a purpose, has joined as a member of the advisory board of the Wockhardt Foundation. - May 05, 2010 - Wockhardt Foundation
New SensoLyte® SIRT1 Assay Kit Offers Industry’s Longest Wavelength
AnaSpec has introduced SIRT1 assay kits in the green range (Ex/Em=490/520 nm). - May 02, 2010 - AnaSpec, EGT Group
Mass Deworming & Eye Screening Camp Held for Children: a Wockhardt Foundation Initiative
A medical camp was conducted by the Mobile Medical Unit of Wockhardt Foundation in Pratiksha Nagar BMC School at Jogeshwari on Thursday 29th April 2010. - May 02, 2010 - Wockhardt Foundation
Huzaifa Khorakiwala Launches the Youth Social Responsibility Movement in Mumbai
Zealous Launch of Youth Social Responsibility Movement at D. Y. Patil College in Mumbai creating Social Awakening among the youth of today. - May 01, 2010 - Wockhardt Foundation
National Brain Tumor Society’s 16th Annual Bay Area Brain Tumor Walk Raising Essential Funds for Brain Tumor Research
National Brain Tumor Society will host a fundraising walk and community day in San Francisco on Saturday, May 1, 2010. Over 2,500 will gather for a 5K walk through scenic Golden Gate Park to raise awareness and essential funds. - April 30, 2010 - National Brain Tumor Society
Health Decisions CEO to Explore the Role of Operations in Adaptive Research at Adaptive Designs for Clinical Drug Development, April 29
Michael Rosenberg, founder of adaptive-focused CRO, will discuss how flexible clinical operations support the new FDA Draft Guidance on adaptive design - April 25, 2010 - Health Decisions
AnaSpec Introduces New MMP Recombinant Proteins
AnaSpec has announced the release of three new MMP recombinant proteins, MMP-1, MMP-9 and MMP-12. These proteins, derived from the catalytic domain of the proteins, are supplied as activated proteins (activation by APMA is not necessary). They can be used as positive controls for the SensoLyte®... - April 25, 2010 - AnaSpec, EGT Group
Mega Health Camps in Mumbai & Baroda: A Wockhardt Foundation Initiative
On 18th April 2010 a Mega Diabetes Camp was held by Wockhardt Foundation in Baroda, Gujarat & simultaneously another medical camp was held at Worli, Mumbai on the same day. - April 22, 2010 - Wockhardt Foundation